Fusion Pharmaceuticals News - FUSN

Company Name	Stock Ticker Symbol	Market	Type
Fusion Pharmaceuticals Inc	FUSN	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.02	-0.09%	21.40	18:00:01

Open Price	Low Price	High Price	Close Price	Prev Close
21.43	21.34	21.44	21.40	21.42

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	16:05	PRNUS	Fusion Pharmaceuticals Announces Presentation of Interim..
3/20/2024	16:10	PRNUS	Kuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
3/20/2024	16:05	PRNCA	Fusion Pharmaceuticals Reports Fourth Quarter and Full Year..
3/19/2024	03:00	PRNCA	Fusion Pharmaceuticals to be Acquired by AstraZeneca,..
3/06/2024	07:45	PRNUS	Fusion Pharmaceuticals Announces Inducement Grants Under..
3/05/2024	16:43	PRNUS	Fusion Pharmaceuticals to Present Interim Data from the..
2/26/2024	07:45	PRNCA	Fusion Pharmaceuticals to Present at Upcoming March Investor..
2/16/2024	16:05	EDGAR2	Form 8-K - Current report
2/16/2024	08:45	PRNUS	Fusion Pharmaceuticals Enters into Exclusive Worldwide..
2/07/2024	07:45	PRNUS	Fusion Pharmaceuticals to Present at the Oppenheimer 34th..
2/06/2024	16:45	PRNCA	Fusion Pharmaceuticals Announces Inducement Grants Under..
1/19/2024	16:13	EDGAR2	Form 8-K - Current report
1/19/2024	16:10	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/05/2024	08:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	08:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	08:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	08:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	06:14	IHMARKETNEWS	Wall Street Highlights: Google Rejects Union Negotiations,..
1/04/2024	18:53	DJN	Shares of Fusion Pharmaceuticals Rise 7.8% With Study..
1/04/2024	16:31	EDGAR2	Form 8-K - Current report
1/04/2024	16:05	PRNUS	Fusion Pharmaceuticals Announces Clinical Program and..
11/16/2023	06:45	PRNCA	Fusion Pharmaceuticals Strengthens Actinium Supply with..
11/08/2023	16:15	PRNUS	Fusion Pharmaceuticals Announces Inducement Grants Under..
11/08/2023	08:15	PRNUS	Fusion Pharmaceuticals to Present at Upcoming Investor..
11/07/2023	08:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:45	EDGAR2	Form 8-K - Current report
11/07/2023	07:00	PRNCA	Fusion Pharmaceuticals Announces Third Quarter 2023..
10/16/2023	16:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/16/2023	16:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/16/2023	16:56	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/16/2023	16:30	EDGAR2	Form 8-K - Current report
10/16/2023	07:50	PRNCA	Fusion Pharmaceuticals Appoints Life Science Industry..
10/12/2023	07:45	PRNUS	Fusion Pharmaceuticals Announces Presentation of Preclinical..
9/06/2023	16:25	PRNUS	Fusion Pharmaceuticals Announces Inducement Grants Under..
9/05/2023	16:10	PRNCA	Fusion Pharmaceuticals to Present at Upcoming September..
8/09/2023	16:05	PRNUS	Fusion Pharmaceuticals Announces Inducement Grants Under..
8/08/2023	08:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	07:30	EDGAR2	Form 8-K - Current report
8/08/2023	07:00	PRNUS	Fusion Pharmaceuticals Announces Second Quarter 2023..
7/06/2023	16:05	PRNCA	Fusion Pharmaceuticals Announces Inducement Grants Under..
6/26/2023	08:05	PRNCA	Fusion Pharmaceuticals to Present Interim Data from Phase 1..
6/16/2023	08:05	PRNCA	Fusion Pharmaceuticals to Present at the TD Cowen..
6/07/2023	07:35	PRNUS	Fusion Pharmaceuticals Announces Inducement Grants Under..
5/31/2023	16:10	PRNCA	Fusion Pharmaceuticals to Present at the Jefferies..
5/11/2023	07:15	PRNUS	Fusion Pharmaceuticals Announces First Quarter 2023..
5/09/2023	07:45	PRNUS	Fusion Pharmaceuticals to Present at the Guggenheim..
5/02/2023	16:00	PRNCA	Fusion Pharmaceuticals Announces Opening of..